13F Data
13F filer · CIK 1792206

Foresite Capital Management V, LLC

WEST HOLLYWOOD, CA · filing since Q4 2020 · last filing Aug 14, 2026
Reported value
$362.2M
+$91.2M vs prior
Positions
9
New / sold out
1 / 1
Added / reduced
2 / 1
Turnover
0.2%
buys $34.9M · sells $783.0K
Top-10 weight
100.0%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
AddedPharvaris N.V.+470,017+242.1%+$16.3M
NewOdyssey Therapeutics, Inc.+713,105–+$13.3M
AddedCG Oncology, Inc.+75,000+7.5%+$5.3M

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
Sold outMaze Therapeutics, Inc.-25,905-100.0%$-773.3K
ReducedLyell Immunopharma, Inc.-692-0.1%$-9.7K

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2020: $135.0MQ1 2021: $340.2MQ2 2021: $254.2MQ3 2021: $321.8MQ4 2021: $407.0MQ1 2022: $244.9MQ2 2022: $143.1MQ3 2022: $130.1MQ4 2022: $128.8MQ1 2023: $135.3MQ2 2023: $136.9MQ3 2023: $62.7MQ4 2023: $73.4MQ1 2024: $106.5MQ2 2024: $156.6MQ3 2024: $143.9MQ4 2024: $120.2MQ1 2025: $87.6MQ2 2025: $80.7MQ3 2025: $108.7MQ4 2025: $164.4MQ1 2026: $271.0MQ2 2026: $362.2M
Q4 2020Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1ALUMIS INC.COM5,896,995$165.9M45.81%
2CG Oncology, Inc.COM1,079,050$76.7M21.17%
3Disc Medicine, Inc.COM374,069$27.4M7.55%
4Hims & Hers Health, Inc.COM CL A738,151$25.6M7.07%
5Pharvaris N.V.COM664,142$23.0M6.34%
6Eikon Therapeutics, Inc.COM1,318,983$17.2M4.75%
7Odyssey Therapeutics, Inc.COM713,105$13.3M3.68%
8Lyell Immunopharma, Inc.COM476,386$6.7M1.85%
9Nurix Therapeutics, Inc.COM265,000$6.4M1.77%